GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
14.32
+1.78 (14.19%)
At close: Oct 31, 2025, 4:00 PM EDT
14.04
-0.28 (-1.96%)
After-hours: Oct 31, 2025, 4:55 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $888.26 million as of October 31, 2025. Its market cap has increased by 135.49% in one year.
Market Cap
888.26M
Enterprise Value
580.22M
1-Year Change
135.49%
Ranking
Category
Stock Price
$14.32
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $888.26M, an increase of 9.89%. That is a compound annual growth rate of 2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 854.14M | 134.53% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 774.01B |
| Johnson & Johnson | 453.55B |
| AbbVie | 387.78B |
| UnitedHealth Group | 307.53B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 214.12B |